samuthara chooranam for Irritable bowel syndrome(maha vatham)

Phase 2

Not yet recruiting

• Conditions: Irritable bowel syndrome with diarrhea,

• Registration Number: CTRI/2021/11/037781
• Lead Sponsor: Government Siddha Medical College

Brief Summary

This is a single Non randomised open clinical trial to study the safety and efficacy of siddha trial drug samuthara chooranam . The trial drug is given 6grams twice a day for 48 days. Clinical trial is conducted after conducting pre clinical toxicity study. The trial drug samuthara chooranam is mentioned in kosaye anuboga vaithiya brahma ragasiyam. During the trial all the study related data will be recorded and documented. After the completion of the trial all the data will be analysed statistically.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2021-01-11
• Study Start: 2021-10-11

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Both gender ,age limit below 60 years Altered bowel habits Abdominal pain or discomfort often exacerbated by eating Abdominal distension and increased belching Dyspepsia ,heartburn, nausea.

Exclusion Criteria

Ulcerative colitis Colon cancer.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome is mainly assessed by reduction in the clinical symptoms.	48 days

Secondary Outcome Measures

Name	Time	Method
Secondary outcome is assessed by comparing before and after treatment.	48 days

Trial Locations

Locations (1)

Arignar Anna Hospital of Indian Medicine and Homoeopathy; 🇮🇳 Chennai, TAMIL NADU, India

Arignar Anna Hospital of Indian Medicine and Homoeopathy

🇮🇳Chennai, TAMIL NADU, India

P Suganya

Principal investigator

6383982810

suganyamyindia@gmail.com